Public Health


World Mental Health Day 2022: Three in four globally say mental and physical health are equally important

Mental health now ranks 2nd among global health concerns, overtaking cancer
Covid-19 Survey

Covid-19: Expectations and vaccination

Majorities in each of 30 countries believe we will never fully stop the spread of COVID, but views on vaccination mandates vary widely.
Covid-19 Survey

Covid-19: Will the pandemic ever end and how will we know?

There is no consensus on what would signal the end of the pandemic. In most of the 33 countries surveyed, the majority don’t expect it’ll happen any time soon.
Public Health Survey

Global Health Service Monitor 2021

Public perceptions of healthcare services have not been adversely affected by the pandemic, according to our 30-country survey. People continue to see coronavirus as the main health problem facing their country, while concern about mental health increases.
Sustainability Publication

The Rewired Consumer - Tetra Pak Index 2021

The pandemic has forced people to rethink their priorities and behaviours as they seek a more resilient and sustainable future. The 2021 Tetra Pak Index conducted in partnership with Ipsos explores shopper attitudes and action today when it comes to food, health and the environment.
Coronavirus Survey

What Worries the World: How has Covid-19 has changed the outlook?

Local perspectives on our issues tracker during the pandemic.
Sports Survey

Global views on sports: 58% globally would like to practice more.

A new global Ipsos study conducted with the World Economic Forum explores attitudes to sports and finds that globally most (58%) would like to practice more but say they lack of time to do so (37%).
Healthcare Publication

氣喘與慢性阻塞性肺病的趨勢及變化

肺阻塞佔世界死因排名第四,預估將持續攀升。越來越多國際藥廠投入相關治療用藥,市場也發生了明顯的變化。LABA聯合LAMA將取代ICS聯合LABA FDC,成為肺阻塞的主要治療選擇並持續增長。而ICS聯合LABA FDC在氣喘治療的競爭更加激烈,差異化需求逐漸增加。
Chronic obstructive pulmonary disease (COPD) is now the fourth leading cause of death worldwide and is predicted by WHO to become the third by 2030. More and more international pharmaceuticals have increased investment in treatments for respiratory diseases, bringing significant changes to COPD and Asthma treatment market. LABA/LAMA has replaced ICS/LABA FDC to become the leading treatment choice for COPD and will continue its growth. We also found Increased competition of ICS/LABA FDC as asthma treatment, as well as the needs for differentiation.
Public Health Survey

英政府欲課糖稅,改成代糖消費者買單嗎?

雖然小尺寸的身材是許多人夢寐以求的,但是他們其實並不會一味地追求「無糖」,大部分消費者普遍認為無糖產品裡面含的代糖或人工添加物都是不健康的。
Whilst we’re seeing some appetite for reduced sugar options, sugar-free products are currently still viewed with scepticism by consumers.